High expression of DNMT3B negatively impacts on clinical outcome of older patients (pts) with primary cytogenetically normal (CN) acute myeloid leukemia (AML) [CALGB 20202 (Alliance)].
- Citation:
- European Hematology Association Congress abstr S1168
- Meeting Instance:
- EHA 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 2187
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- C. Niederwieser J. Kohlschmidt K. Maharry K. Mrózek K. H. Metzeler S. Volinia P. Yan D. Frankhouser S. P. Whitman H. Becker Ann-Kathrin Eisfeld S. Schwind J. Curfman Y.-Z. Wu M. R. Baer B. L. Powell J. E. Kolitz J. O. Moore T. H. Carter G. Marcucci C. D. Bloomfield
- Networks:
- Study
- CALGB-20202
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords: